Cutaneous lesions of secondary syphilis are highly angiogenic.

BACKGROUND The role of angiogenesis in infectious processes is poorly studied. Some viruses have been linked to angiogenesis, but the role of bacteria and protozoa in inducing angiogenesis in chronic infections is poorly understood. OBJECTIVES We examined the role of angiogenesis in syphilis, a common and often difficult-to-treat infectious disease, especially in the setting of HIV/AIDS. METHOD Microvessel counts were performed on 27 paraffin-fixed sections of secondary syphilis by staining with monoclonal antibodies against CD31. In addition, immunohistochemistry was performed using antibodies against vascular endothelial growth factor (VEGF) to determine whether increased angiogenesis may be mediated, in part, through increased production of VEGF. RESULTS The CD31 mean microvessel count in secondary syphilis sections was significantly higher than in normal control sections. VEGF intensity appeared increased in the patients with secondary syphilis. CONCLUSIONS Infection with Treponema pallidum results in increased angiogenesis in secondary syphilis. The mechanism for increased angiogenesis may involve elaboration of angiogenic cytokines, such as VEGF and epidermal growth factor.

[1]  D. Brat,et al.  Tuberous sclerosis-associated lesions of the kidney, brain, and skin are angiogenic neoplasms. , 2002, Journal of the American Academy of Dermatology.

[2]  M. Ostrowski,et al.  Quantitative and qualitative assessment of human immunodeficiency virus type 1 (HIV-1)-specific CD4+ T cell immunity to gag in HIV-1-infected individuals with differential disease progression: reciprocal interferon-gamma and interleukin-10 responses. , 2001, The Journal of infectious diseases.

[3]  K. Shuai,et al.  A Role for IL-12 Receptor Expression and Signal Transduction in Host Defense in Leprosy1 , 2001, The Journal of Immunology.

[4]  Y. Oshika,et al.  Significant correlation between interleukin 10 expression and vascularization through angiopoietin/TIE2 networks in non-small cell lung cancer. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[5]  J. Arbiser,et al.  Differential expression of active mitogen-activated protein kinase in cutaneous endothelial neoplasms: implications for biologic behavior and response to therapy. , 2001, Journal of the American Academy of Dermatology.

[6]  H. J. Choi,et al.  Virulent Treponema pallidum 47 kDa antigen regulates the expression of cell adhesion molecules and binding of T-lymphocytes to cultured human dermal microvascular endothelial cells. , 2000, Yonsei medical journal.

[7]  H. Saji,et al.  Significance of macrophage chemoattractant protein-1 in macrophage recruitment, angiogenesis, and survival in human breast cancer. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[8]  C. Cockerell,et al.  Secondary syphilis in persons infected with and not infected with HIV-1: a comparative immunohistologic study. , 1999, The American Journal of dermatopathology.

[9]  G. Gaidano,et al.  Lymphoma cell lines: in vitro models for the study of HHV-8+ primary effusion lymphomas (body cavity-based lymphomas) , 1998, Leukemia.

[10]  Ramsingh,et al.  Cytokine gene expression in skin of susceptible guinea‐pig infected with Treponema pallidum , 1998, Immunology.

[11]  T. Rosen,et al.  Cutaneous manifestations of sexually transmitted diseases. , 1998, The Medical clinics of North America.

[12]  J. Arbiser,et al.  Analysis of vascularity of human neurofibromas. , 1998, Journal of the American Academy of Dermatology.

[13]  R. Gaynor,et al.  Treponema pallidum, lipoproteins, and synthetic lipoprotein analogues induce human immunodeficiency virus type 1 gene expression in monocytes via NF-kappaB activation. , 1998, The Journal of infectious diseases.

[14]  D. Spach,et al.  Bartonella-associated infections. , 1998, Infectious disease clinics of North America.

[15]  B. Spellberg,et al.  Interferon-gamma differentially regulates interleukin-12 and interleukin-10 production in leprosy. , 1997, The Journal of clinical investigation.

[16]  D. Hanahan,et al.  Patterns and Emerging Mechanisms of the Angiogenic Switch during Tumorigenesis , 1996, Cell.

[17]  J. Arbiser.  Angiogenesis and the skin: a primer. , 1996, Journal of the American Academy of Dermatology.

[18]  W. V. Voorhis,et al.  Primary and Secondary Syphilis Lesions Contain mRNA for Thl Cytokines , 1996 .

[19]  P. Don,et al.  MALIGNANT SYPHILIS (LUES MALIGNA) AND CONCURRENT INFECTION WITH HIV , 1995, International journal of dermatology.

[20]  R. D'Amato,et al.  Inhibition of angiogenesis in vivo by interleukin 12. , 1995, Journal of the National Cancer Institute.

[21]  J. Radolf,et al.  Dermal inflammation elicited by synthetic analogs of Treponema pallidum and Borrelia burgdorferi lipoproteins , 1995, Infection and immunity.

[22]  N. Oppenheimer-Marks,et al.  Virulent Treponema pallidum promotes adhesion of leukocytes to human vascular endothelial cells , 1994, Infection and immunity.

[23]  C. Cockerell,et al.  Early oral presentation of lues maligna in a patient with HIV infection. A case report. , 1993, Oral surgery, oral medicine, and oral pathology.

[24]  F Pozza,et al.  Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma. , 1992, Journal of the National Cancer Institute.

[25]  B. Nahlen,et al.  Immunity to placental malaria. III. Impairment of interleukin(IL)-12, not IL-18, and interferon-inducible protein-10 responses in the placental intervillous blood of human immunodeficiency virus/malaria-coinfected women. , 2002, The Journal of infectious diseases.

[26]  D. Diven.  An overview of poxviruses. , 2001, Journal of the American Academy of Dermatology.

[27]  R. Patarca,et al.  Verruga peruana: an infectious endemic angiomatosis. , 1995, Critical reviews in oncogenesis.

[28]  T. Wrzołkowa,et al.  Treponema pallidum in lesions of early syphilis. , 1976, Annals of the Medical Section of the Polish Academy of Sciences.